Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion

T 细胞耗竭中的表型、功能和转录异质性

基本信息

  • 批准号:
    10536743
  • 负责人:
  • 金额:
    $ 6.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-12-16 至 2022-08-26
  • 项目状态:
    已结题

项目摘要

ABSTRACT T cell exhaustion is a differentiation state that is marked by the loss of effector function and increased expression of inhibitory receptors such as PD-1. Although virus-specific CD8 T cells are commonly considered as a homogeneous population that gradually become exhausted over time, recent research has clearly demonstrated that a CXCR5hi TCF-1hi subset is serving as a self-renewing progenitor population that can give rise to a more terminally exhausted CXCR5lo TCF-1lo subset. To better dissect the heterogeneity of “exhausted” CD8 T cells, the lab applied single cell RNA-seq (scRNA-seq) to the chronic LCMV infection and identified three major subsets of virus-specific CD8 T cells that are phenotypically, functionally and transcriptionally distinct. Not only had the lab validated the existence of these subsets of T cells experimentally by flow cytometry, more advanced computational analyses were also performed to further predict their core transcriptional networks and developmental trajectories. Collectively, the findings reveal that a TCF-1hi progenitor subset can give rise to either a truly exhausted PD-1hi subset or a newly identified functional effector population that is named CX3CR1hi subset. This discovery laid a solid framework that allows testing of how extracellular signals and intrinsic genetic circuits regulate the formation and function of these three subsets of CD8 T cells. More importantly, it provides unprecedented opportunities to explore the possibility of generating more functional CX3CR1hi cells from TCF-1hi progenitors to overcome T cell exhaustion. This conceptual breakthrough is obviously applicable to control over chronic viral infection as well as cancer. Intriguingly, the preliminary study has also demonstrated that CD4 helper T cells, possibly through producing IL-21, are critical for TCF-1hi  CX3CR1hi transition. This led to the hypothesis that inflammatory cytokines (such as CD4- derived IL-21) modulate the cellular, functional and transcriptional diversity of virus-specific CD8 T cells during chronic LCMV infection. Blocking antibodies, RNA interference and genetic deletion models will be used to further dissect how inflammatory cytokines and transcriptional networks regulate heterogeneity in T cell exhaustion. Furthermore, the lab proposes to redirect CD8 T cell differentiation away from “exhaustion” by providing additional “CD4 help”, either alone or in combination with PD-1 blockade. The lab will test if providing IL-21 producing CD4 T cells through adoptive transfer could drive TCF-1hi progenitor cell differentiation into functional CX3CR1hi effector cells. Overall, knowledge gained from this research will provide mechanistic insights into how to redirect the formation of functional effector T cells and simultaneously limit T cell exhaustion for improved viral control over chronic infection.
摘要 T细胞耗竭是一种分化状态,其特征是效应功能丧失,并且T细胞功能增强。 抑制性受体如PD-1的表达。虽然病毒特异性CD 8 T细胞通常被认为是 作为一个同质的人口,随着时间的推移逐渐变得疲惫不堪,最近的研究显然 证明了CXCR 5 hi TCF-1hi亚群作为自我更新的祖细胞群体, 上升到更终末耗尽的CXCR 510 TCF-110亚群。为了更好地剖析“筋疲力尽”的异质性, CD 8 T细胞,该实验室将单细胞RNA-seq(scRNA-seq)应用于慢性LCMV感染,并鉴定了 病毒特异性CD 8 T细胞的三个主要亚群,其在表型、功能和转录上 与众不同该实验室不仅通过流式细胞术验证了这些T细胞亚群的存在, 细胞计数,更先进的计算分析也进行了进一步预测其核心 转录网络和发展轨迹。总的来说,研究结果表明,TCF-1hi 祖细胞亚群可以产生真正耗尽的PD-1hi亚群或新鉴定的功能效应子 CX 3CR 1hi亚群。这一发现奠定了坚实的框架,允许测试如何 细胞外信号和内在遗传回路调节这三个亚群的形成和功能。 CD 8 T细胞。更重要的是,它提供了前所未有的机会,探索产生的可能性 来自TCF-1hi祖细胞的功能更强的CX 3CR 1hi细胞,以克服T细胞耗竭。这个概念 这一突破显然适用于控制慢性病毒感染和癌症。有趣的是, 初步研究还表明,CD 4辅助性T细胞,可能通过产生IL-21, TCF-1hi → CX_3CR_1hi跃迁。这导致了一种假设,即炎症细胞因子(如CD 4- 衍生的IL-21)调节病毒特异性CD 8 T细胞的细胞、功能和转录多样性。 慢性LCMV感染。阻断抗体、RNA干扰和遗传缺失模型将用于 进一步剖析炎性细胞因子和转录网络如何调节T细胞异质性 疲惫不堪此外,该实验室还提出通过以下方法来重定向CD 8 T细胞分化,使其远离“耗竭”。 单独或与PD-1阻断剂组合提供额外的“CD 4帮助”。实验室将测试是否提供 通过过继转移产生IL-21的CD 4 T细胞可以驱动TCF-1hi祖细胞分化为 功能性CX 3CR 1hi效应细胞。总体而言,从这项研究中获得的知识将提供机械性 深入了解如何重新定向功能性效应T细胞的形成,同时限制T细胞 用于改善对慢性感染的病毒控制的衰竭。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WEIGUO CUI其他文献

WEIGUO CUI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WEIGUO CUI', 18)}}的其他基金

Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
  • 批准号:
    10743327
  • 财政年份:
    2022
  • 资助金额:
    $ 6.14万
  • 项目类别:
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages
Pim1 激酶协调 PPAR gamma 通路和线粒体功能,介导巨噬细胞中的促动脉粥样硬化反应
  • 批准号:
    10209655
  • 财政年份:
    2021
  • 资助金额:
    $ 6.14万
  • 项目类别:
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages
Pim1 激酶协调 PPAR gamma 通路和线粒体功能,介导巨噬细胞中的促动脉粥样硬化反应
  • 批准号:
    10591599
  • 财政年份:
    2021
  • 资助金额:
    $ 6.14万
  • 项目类别:
The cellular mechanisms of immunological memory development in COVID-19 patients
COVID-19患者免疫记忆发展的细胞机制
  • 批准号:
    10745497
  • 财政年份:
    2021
  • 资助金额:
    $ 6.14万
  • 项目类别:
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages
Pim1 激酶协调 PPAR gamma 通路和线粒体功能,介导巨噬细胞中的促动脉粥样硬化反应
  • 批准号:
    10372226
  • 财政年份:
    2021
  • 资助金额:
    $ 6.14万
  • 项目类别:
The cellular mechanisms of immunological memory development in COVID-19 patients
COVID-19患者免疫记忆发展的细胞机制
  • 批准号:
    10465343
  • 财政年份:
    2021
  • 资助金额:
    $ 6.14万
  • 项目类别:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
  • 批准号:
    10721409
  • 财政年份:
    2019
  • 资助金额:
    $ 6.14万
  • 项目类别:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
  • 批准号:
    10428867
  • 财政年份:
    2019
  • 资助金额:
    $ 6.14万
  • 项目类别:
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
T 细胞耗竭中的表型、功能和转录异质性
  • 批准号:
    10311054
  • 财政年份:
    2019
  • 资助金额:
    $ 6.14万
  • 项目类别:
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic Viruses
CD8 T 细胞功能适应慢性病毒的细胞和转录控制
  • 批准号:
    9160163
  • 财政年份:
    2016
  • 资助金额:
    $ 6.14万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 6.14万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 6.14万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 6.14万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 6.14万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 6.14万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 6.14万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 6.14万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 6.14万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 6.14万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 6.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了